Information:
Fel:
ID
14224
Beskrivning
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013); ODM derived from: https://clinicaltrials.gov/show/NCT00163527
Länk
https://clinicaltrials.gov/show/NCT00163527
Nyckelord
Versioner (1)
- 2016-04-05 2016-04-05 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
5 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Asthma NCT00163527
Eligibility Asthma NCT00163527
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00163527
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Hyperimmunized patients and Panel-reactive antibody
Item
hyperimmunized patients at the transplant time or in the previous 6 month, with a pra of 50 %
boolean
C0301877 (UMLS CUI [1,1])
C1141951 (UMLS CUI [1,2])
C1141951 (UMLS CUI [1,2])
Liver disease
Item
patients with evidence of advanced liver disease
boolean
C0023895 (UMLS CUI [1])
Serum potassium
Item
serum potassium <3.5 or >5.5 meq/l
boolean
C0202194 (UMLS CUI [1])
Allergy to losartan
Item
history of allergy to losartan
boolean
C0020517 (UMLS CUI [1,1])
C0126174 (UMLS CUI [1,2])
C0126174 (UMLS CUI [1,2])
Factors affecting participation
Item
other factors which may affect participation (e.g., significant concurrent or life limiting disease such as cancer in the last five year except skin neoplasias, mental or legal incapacitation, drug or alcohol abuse within the last 2 years, extensive travel planned in the next 3 years, investigative drug trial within the last 4 weeks)
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0679823 (UMLS CUI [1,3])
C0392760 (UMLS CUI [1,2])
C0679823 (UMLS CUI [1,3])
Disseminated or localized active infectious disease
Item
patients with disseminated or localized active infectious disease, at the time of transplant
boolean
C0205221 (UMLS CUI [1,1])
C3262321 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C3262321 (UMLS CUI [2,2])
C3262321 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C3262321 (UMLS CUI [2,2])
acute graft rejection
Item
acute graft rejection in the grade iii of banff classification
boolean
C1736177 (UMLS CUI [1])
Reno-pancreatic transplant
Item
patients with double-transplant (reno-pancreatic)
boolean
C0030275 (UMLS CUI [1,1])
C0022671 (UMLS CUI [1,2])
C0022671 (UMLS CUI [1,2])
Cardiovascular status
Item
patients with heart failure or history of myocardial infarction requiring ace inhibitor or aiia therapies. presence or known history of hemodynamically significant obstructive valvular disease or hypertrophic cardiomyopathy
boolean
C0018801 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0003015 (UMLS CUI [3])
C1384985 (UMLS CUI [4])
C0007194 (UMLS CUI [5])
C0027051 (UMLS CUI [2])
C0003015 (UMLS CUI [3])
C1384985 (UMLS CUI [4])
C0007194 (UMLS CUI [5])
Eco-doppler test: renal graft artery stenosis
Item
renal graft artery stenosis. an eco-doppler test must be performed in order to exclude a graft artery stenosis
boolean
C0035067 (UMLS CUI [1,1])
C0022671 (UMLS CUI [1,2])
C0162481 (UMLS CUI [1,3])
C0022671 (UMLS CUI [1,2])
C0162481 (UMLS CUI [1,3])
Gynaecological status
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
Chronic use of nsaids
Item
chronic use of nsaids
boolean
C0003211 (UMLS CUI [1,1])
C1398175 (UMLS CUI [1,2])
C1398175 (UMLS CUI [1,2])
Phenothiazines or lithium
Item
major psychotropic agents such as phenothiazines are not permitted, use of lithium is not permitted
boolean
C0031436 (UMLS CUI [1])
C3540800 (UMLS CUI [2])
C3540800 (UMLS CUI [2])